Gonzalez-Orozco Maria, Barbosa-Cobos Rosa E, Santana-Sanchez Paola, Becerril-Mendoza Lizbeth, Limon-Camacho Leonardo, Juarez-Estrada Ana I, Lugo-Zamudio Gustavo E, Moreno-Rodriguez Jose, Ortiz-Navarrete Vianney
1Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Av IPN 2508, 07360 Mexico City, Mexico.
2Servicio de Reumatología, Hospital Juarez de Mexico, Av. IPN 5160, 07760 Mexico City, Mexico.
Allergy Asthma Clin Immunol. 2019 Aug 1;15:44. doi: 10.1186/s13223-019-0359-9. eCollection 2019.
Neutrophils play an important role in the pathogenesis of rheumatoid arthritis (RA). It has recently been reported that in addition to T helper (Th) 17 cells, other cells, including neutrophils, produce IL-17A, an important inflammatory cytokine involved in the pathogenesis of RA. The purpose of this study was to examine the presence of interleukin 17A-producing neutrophils in patients with RA.
We performed a cross-sectional study including 106 patients with RA and 56 healthy individuals. Whole peripheral blood cells were analyzed by flow cytometry to identify CD66b+ CD177+ IL-17A+ neutrophils and CD3+ CD4+ IL-17A+ T cells. Serum levels of IL-17A and IL-6 were measured by means of cytometry bead array (CBA). In purified neutrophils, mRNA levels of IL-17 and RORγ were measured by RT-PCR. In addition, purified neutrophils from patients and healthy controls were stimulated with the cytokines IL-6 and IL-23 to evaluate differences in their capacity to produce IL-17A.
Neutrophils from RA patients expressed IL-17 and RORγ mRNA. Consequently, these cells also expressed IL-17A. Serum IL-17A levels but not Th17 cell numbers were increased in RA patients. Neutrophils positive for cytoplasmic IL-17A were more abundant in patients with RA (mean 1.2 ± 3.18%) than in healthy individuals (mean 0.07 ± 0.1%) (< 0.0001). Although increased IL-17A+ neutrophil numbers were present in RA patients regardless of disease activity (mean 6.5 ± 5.14%), they were more frequent in patients with a more recent diagnosis (mean time after disease onset 3.5 ± 4.24 years). IL-6 and IL-23 induced the expression of RORγ but failed to induce IL-17A expression by neutrophils from RA patients and healthy individuals after a 3 h stimulation.
IL-17A-producing neutrophils are increased in some RA patients, which are not related to disease activity but have an increased frequency in patients with recent-onset disease. This finding suggests that IL-17A-producing neutrophils play an early role in the development of RA.
中性粒细胞在类风湿关节炎(RA)的发病机制中起重要作用。最近有报道称,除了辅助性T细胞(Th)17细胞外,包括中性粒细胞在内的其他细胞也会产生白细胞介素17A(IL-17A),这是一种参与RA发病机制的重要炎性细胞因子。本研究的目的是检测RA患者中产生白细胞介素17A的中性粒细胞的存在情况。
我们进行了一项横断面研究,纳入了106例RA患者和56名健康个体。通过流式细胞术分析全外周血细胞,以鉴定CD66b + CD177 + IL-17A +中性粒细胞和CD3 + CD4 + IL-17A + T细胞。通过细胞计数珠阵列(CBA)测定血清IL-17A和IL-6水平。在纯化的中性粒细胞中,通过逆转录聚合酶链反应(RT-PCR)测定IL-17和维甲酸相关孤儿受体γ(RORγ)的mRNA水平。此外,用细胞因子IL-6和IL-23刺激来自患者和健康对照的纯化中性粒细胞,以评估它们产生IL-17A能力的差异。
RA患者的中性粒细胞表达IL-17和RORγ mRNA。因此,这些细胞也表达IL-17A。RA患者血清IL-17A水平升高,但Th17细胞数量未增加。胞质IL-17A阳性的中性粒细胞在RA患者中(平均1.2±3.18%)比在健康个体中(平均0.07±0.1%)更丰富(<0.0001)。尽管无论疾病活动度如何,RA患者中IL-17A +中性粒细胞数量均增加(平均6.5±5.14%),但在诊断时间更近的患者中(疾病发作后的平均时间3.5±4.24年)更常见。IL-6和IL-23诱导RORγ表达,但在3小时刺激后未能诱导RA患者和健康个体的中性粒细胞表达IL-17A。
在一些RA患者中,产生IL-17A的中性粒细胞增加,这与疾病活动度无关,但在近期发病的患者中频率增加。这一发现表明,产生IL-17A的中性粒细胞在RA的发展中起早期作用。